InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,565.42
(
-0.03%
)
US TECH 100
19,896.40
(
0.25%
)
Dow Jones
39,302.86
(
-0.19%
)
Brent Oil
85.53
(
-1.13%
)
Bitcoin
56,040.80
(
0.35%
)
Post# of 252510
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119985
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 202179

Wednesday, 10/12/2016 4:46:49 PM

Wednesday, October 12, 2016 4:46:49 PM

Post# of 252510
TGTX CC tomorrow* re amending phase-3 GENUINE study:

http://finance.yahoo.com/news/tg-therapeutics-inc-host-conference-203000362.html

TG Therapeutics will announce details of the amendments in a press release to be issued prior to the call.

The trial being amended is testing Ibruvica ± Ublituximab in second-line CLL (https://clinicaltrials.gov/ct2/show/NCT02301156 ).

The stock is down about 10% in AH trading.

*8:30am ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up